Search results
Results from the WOW.Com Content Network
Nalmefene, sold under the brand name Revex among others, is a medication that is used in the treatment of opioid overdose and alcohol dependence. [ 2 ] [ 3 ] Nalmefene belongs to the class of opioid antagonists and can be taken by mouth , administered by injection, or delivered through nasal administration.
Disulfiram is a medication used to support the treatment of chronic alcoholism by producing an acute sensitivity to ethanol (drinking alcohol). Disulfiram works by inhibiting the enzyme aldehyde dehydrogenase (specifically the ALDH2 enzyme [3]), causing many of the effects of a hangover to be felt immediately following alcohol consumption.
Cardiac valvular disease, pulmonary hypertension, cardiac fibrosis; [3] [23] re-approved in June 2020 for the treatment of seizures associated with Dravet syndrome, under FDA orphan drug rules. Fenoterol: 1990 New Zealand Asthma mortality. [3] Feprazone: 1984 Germany, UK Cutaneous reaction, multiorgan toxicity. [3] Fipexide: 1991 France ...
Naltrexone is one of three standard FDA-approved medications currently on the market to treat AUD. ... term side effects that patients taking these drugs to lose weight have experienced: nausea ...
A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at curbing alcohol abuse.
These side effects happen to about 1 in 5 patients who take the drug, notes Dr. Trinh. ... FDA approval of Leqembi: U.S. Food and Drug Administration Leqembi study: New England Journal of Medicine
As with all other drugs approved by the FDA for treating epilepsy, the pregabalin labeling warns of an increased suicide risk when combined with other drugs. [ 24 ] [ 13 ] When pregabalin is taken at high doses over a long period of time, addiction may occur, but if taken at usual doses the risk is low. [ 4 ]
GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of conditions. These medications are “slated to make a big clinical impact."